Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results

The paper reviews the results of the GALAXY international programme, a series of clinical (mostly comparative) studies of various statins. It has demonstrated the benefits of rosuvastatin in terms of normalization of lipid profile, inflammatory markers, and coronary or cerebrovascular atherosclerosi...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Britov, M. P. Chupina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1495
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342126820687872
author A. N. Britov
M. P. Chupina
author_facet A. N. Britov
M. P. Chupina
author_sort A. N. Britov
collection DOAJ
description The paper reviews the results of the GALAXY international programme, a series of clinical (mostly comparative) studies of various statins. It has demonstrated the benefits of rosuvastatin in terms of normalization of lipid profile, inflammatory markers, and coronary or cerebrovascular atherosclerosis regression. This makes rosuvastatin medications promising for the prevention of severe organ complications at all atherosclerosis stages.
format Article
id doaj-art-2a74d5a88d20442c8d82168ef98b2e2d
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2011-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-2a74d5a88d20442c8d82168ef98b2e2d2025-08-20T03:43:29Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-02-011011041091213Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme resultsA. N. Britov0M. P. Chupina1State Research Centre for Preventive MedicineState Research Centre for Preventive MedicineThe paper reviews the results of the GALAXY international programme, a series of clinical (mostly comparative) studies of various statins. It has demonstrated the benefits of rosuvastatin in terms of normalization of lipid profile, inflammatory markers, and coronary or cerebrovascular atherosclerosis regression. This makes rosuvastatin medications promising for the prevention of severe organ complications at all atherosclerosis stages.https://cardiovascular.elpub.ru/jour/article/view/1495statinsrosuvastatinlipid-lowering and pleiotropic effectsgalaxy international programme
spellingShingle A. N. Britov
M. P. Chupina
Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
Кардиоваскулярная терапия и профилактика
statins
rosuvastatin
lipid-lowering and pleiotropic effects
galaxy international programme
title Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
title_full Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
title_fullStr Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
title_full_unstemmed Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
title_short Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
title_sort clinical lipid lowering and pleiotropic effectiveness of rosuvastatin a review of the galaxy programme results
topic statins
rosuvastatin
lipid-lowering and pleiotropic effects
galaxy international programme
url https://cardiovascular.elpub.ru/jour/article/view/1495
work_keys_str_mv AT anbritov clinicallipidloweringandpleiotropiceffectivenessofrosuvastatinareviewofthegalaxyprogrammeresults
AT mpchupina clinicallipidloweringandpleiotropiceffectivenessofrosuvastatinareviewofthegalaxyprogrammeresults